Structural and dynamic mechanisms of cannabinoid receptors
Xiucheng Guo1, Fahui Li2, Feng Zhang1
1The Second Affiliated Hospital, and School of Clinical and Basic Medical Sciences of Shandong First Medical University& Shandong Academy of Medical Sciences, Taian, Shandong 271000, China.
Biochemical Pharmacology
|November 30, 2025
Summary
Recent structural studies of cannabinoid receptors offer new insights into their function. This knowledge aids in developing more precise and effective cannabinoid-based therapeutics for various diseases.
Area of Science:
- Neuroscience
- Pharmacology
- Structural Biology
Background:
- Cannabinoids and their G protein-coupled receptors (GPCRs) regulate crucial physiological processes like neuromodulation and metabolic homeostasis.
- The endocannabinoidome's dysregulation is linked to neuropsychiatric disorders, chronic pain, and immune dysfunction.
Purpose of the Study:
- To review recent structural advances in cannabinoid receptors.
- To elucidate mechanisms of receptor activation, allosteric modulation, and transducer coupling.
- To highlight the implications of structural insights for drug discovery.
Main Methods:
- Review of recent scientific literature focusing on structural biology of cannabinoid receptors.
- Analysis of structural data to understand receptor activation and signaling dynamics.
Main Results:
- Detailed structural understanding of cannabinoid receptor activation and conformational changes.
- Insights into allosteric modulation and transducer coupling selectivity.
- Identification of key structural features influencing receptor function.
Conclusions:
- Structural insights into cannabinoid receptors are crucial for understanding their function.
- These advances pave the way for developing targeted cannabinoid therapeutics with improved selectivity and reduced side effects.
- Future drug discovery efforts can leverage these structural findings for enhanced therapeutic precision.
Related Concept Videos
The Two-State Receptor Model
3.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.0K
G Protein-coupled Receptors
16.3K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.3K
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Assembly of Signaling Complexes
6.4K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
744
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
744
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.7K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.7K


